Indivior Pharmaceuticals Inc
INDV
Rang in Aktien
#3838
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aktienkurs
$34.70
Marktkapitalisierung
$4.33B
Veränderung (1 Tag)
-0.20%
Veränderung (1 Jahr)
44.04%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategorie
Healthcare
Kursverlauf für Indivior Pharmaceuticals Inc (INDV)
Höchster Schlusskurs: $35.03 am 2026-10-01
Niedrigster Schlusskurs: $10.90 am 2014-12-01
Niedrigster Schlusskurs: $10.90 am 2014-12-01
Kursverlauf der Aktie von Indivior Pharmaceuticals Inc von 2014 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -1.48% |
| 2025 | 202.98% |
| 2024 | -23.97% |
| 2023 | -28.64% |
| 2022 | 35.86% |
| 2021 | 132.41% |
| 2020 | 154.62% |
| 2019 | -56.62% |
| 2018 | -76.25% |
| 2017 | 41.62% |
| 2016 | 30.92% |
| 2015 | 29.04% |
| 2014 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
